Clinical Trial Update: Efficacy and Safety of Regan Tangjiang for Treating the Common Cold With Wind-heat Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of Regan Tangjiang for the common cold with wind-heat syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• Regan Tangjiang

Snippet

Sponsor: Beijing Da-an Bio-technology Co., Ltd. | Conditions: Cold | Phase 2 | Status: UNKNOWN